Omalizumab usage in chronic urticaria and atopic dermatitis: data from South-East province of Turkey

INTRODUCTION: Omalizumab is a current treatment option for IgE-associated dermatoses, such as urticaria and atopic dermatitis. AIM: To evaluate the clinical and laboratory findings of patients with chronic urticaria and atopic dermatitis who received omalizumab. MATERIAL AND METHODS: This study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Nazik, Hülya, Mülayim, Mehmet Kamil, Öztürk, Perihan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986296/
https://www.ncbi.nlm.nih.gov/pubmed/31998003
http://dx.doi.org/10.5114/ada.2019.91424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986296/
https://www.ncbi.nlm.nih.gov/pubmed/31998003
http://dx.doi.org/10.5114/ada.2019.91424

Ejemplares similares